Cerus Corporation (CERS) is an interesting player in the Healthcare space, with a focus on Biotechnology. The stock has been active on the tape, currently trading at $6.47, up from yesterday’s close by 2.86%. Given the stock’s recent action, it seemed like a good time to take a closer look at the company’s recent data.Fundamental Analysis
Cerus Corporation (CERS) currently trades with a market capitalization of $817.29 Million. That value represents a market adjusting for revenues that have been growing by 101.79 % on a quarterly year/year basis as of the company’s last quarterly report.
You can get a sense of how sustainable that is by a levered free cash flow of -$52.58 Million over the past twelve months. Generally speaking, earnings are expected to hold steady in coming quarters. Analysts are forecasting earnings of -$0.12 on a per share basis this quarter. Perhaps, that suggests something about why 1.91% of the outstanding share supply is held by institutional investors.
It’s important to check the technicals to get a sense of how CERS has been acting. Looking at the stock’s movement on the chart, Cerus Corporation recorded a 52-week high of $6.47. It is now trading 0% off that level. The stock is trading $5.34 its 50-day moving average by -1.13%. The stock carved out a 52-week low down at $1.93.
In recent action, Cerus Corporation (CERS) has made a move of +19.15% over the past month, which has come on Strong relative transaction volume. Over the trailing year, the stock is underperforming the S&P 500 by 12.84, and it’s gotten there by action that has been more volatile on a day-to-day basis than most other stocks on the exchange. In terms of the mechanics underlying that movement, traders will want to note that the stock is trading on a float of 3.59% with $126.32 Million sitting short, betting on future declines. That suggests something of the likelihood of a short squeeze in shares of CERS.